Literature DB >> 12959719

Small bowel tumors.

Emad M Abu-Hamda1, Eyas M Hattab, Patrick M Lynch.   

Abstract

Primary tumors of the small bowel are rare, and their clinical presentation is nonspecific. Consequently, preoperative diagnosis remains the exception rather than the rule. Although the small intestine makes up 75% of the length and 90% of the surface area of the gastrointestinal tract, small bowel tumors make up approximately 3% of all malignant gastrointestinal neoplasms. Primary neoplasms of the small intestine are notorious for their insidious presentation and vague symptoms, including abdominal pain, anorexia, and weight loss. These nonspecific symptoms, coupled with the lack of physical findings, often cause a significant delay in reaching a diagnosis. Because the small bowel has been a relatively inaccessible area to standard endoscopic techniques, contrast radiography has been regarded historically as the gold standard diagnostic modality. The management of primary malignant small bowel tumors is invariably surgical. However, adjuvant chemotherapy and radiotherapy may be warranted, depending on the type of tumor.

Entities:  

Mesh:

Year:  2003        PMID: 12959719     DOI: 10.1007/s11894-003-0051-5

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  64 in total

1.  Malignant gastrointestinal stromal tumors of the small intestine: a review of 50 cases from a prospective database.

Authors:  J A Crosby; C N Catton; A Davis; J Couture; B O'Sullivan; R Kandel; C J Swallow
Journal:  Ann Surg Oncol       Date:  2001 Jan-Feb       Impact factor: 5.344

2.  The effect of surgery and grade on outcome of gastrointestinal stromal tumors.

Authors:  J P Pierie; U Choudry; A Muzikansky; B Y Yeap; W W Souba; M J Ott
Journal:  Arch Surg       Date:  2001-04

3.  Mutations of c-kit JM domain are found in a minority of human gastrointestinal stromal tumors.

Authors:  C A Moskaluk; Q Tian; C R Marshall; C A Rumpel; D W Franquemont; H F Frierson
Journal:  Oncogene       Date:  1999-03-11       Impact factor: 9.867

Review 4.  Gastrointestinal stromal tumors--definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis.

Authors:  M Miettinen; J Lasota
Journal:  Virchows Arch       Date:  2001-01       Impact factor: 4.064

5.  An analysis of 8305 cases of carcinoid tumors.

Authors:  I M Modlin; A Sandor
Journal:  Cancer       Date:  1997-02-15       Impact factor: 6.860

6.  CT evaluation of small bowel neoplasms: spectrum of disease.

Authors:  J A Buckley; E K Fishman
Journal:  Radiographics       Date:  1998 Mar-Apr       Impact factor: 5.333

7.  The continuing clinical dilemma of primary tumors of the small intestine.

Authors:  D L Ciresi; D J Scholten
Journal:  Am Surg       Date:  1995-08       Impact factor: 0.688

8.  Primary adenocarcinoma of the jejunum and ileum. A clinicopathologic study.

Authors:  M F Bridge; K H Perzin
Journal:  Cancer       Date:  1975-11       Impact factor: 6.860

9.  Leiomyosarcoma of the small and large bowel.

Authors:  O E Akwari; R R Dozois; L H Weiland; O H Beahrs
Journal:  Cancer       Date:  1978-09       Impact factor: 6.860

10.  Does bile promote extra-colonic cancer?

Authors:  A B Lowenfels
Journal:  Lancet       Date:  1978-07-29       Impact factor: 79.321

View more
  3 in total

1.  Signet Ring Cell Lymphoma of the Small Bowel: A case report.

Authors:  Norwani Basir; Ian C Bickle; Pemasari Upali Telisinghe; Muhd Syafiq Abdullah; Vui Heng Chong
Journal:  Oman Med J       Date:  2012-11

Review 2.  Small bowel capsule endoscopy: Where are we after almost 15 years of use?

Authors:  Cedric Van de Bruaene; Danny De Looze; Pieter Hindryckx
Journal:  World J Gastrointest Endosc       Date:  2015-01-16

Review 3.  Intraductal papillary mucinous neoplasm originating from a jejunal heterotopic pancreas: report of a case.

Authors:  Hiroshi Okamoto; Fumiyoshi Fujishima; Kazuyuki Ishida; Ken Tsuchida; Takuya Shimizu; Hitoshi Goto; Akira Sato; Susumu Satomi; Hironobu Sasano
Journal:  Surg Today       Date:  2013-01-18       Impact factor: 2.549

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.